MASLD biomarkers: Are we facing a new era?
Gastroenterol Hepatol. 2024 Apr;47(4):393-396.
doi: 10.1016/j.gastrohep.2024.02.004.
Epub 2024 Feb 13.
[Article in
English,
Spanish]
Affiliations
- 1 SeLiver Group, Instituto de Biomedicina de Sevilla/CSIC/Universidad de Sevilla, Sevilla, Spain; Hepatic and Digestive Diseases Networking Biomedical Research Centre (CIBERehd), Madrid, Spain.
- 2 SeLiver Group, Instituto de Biomedicina de Sevilla/CSIC/Universidad de Sevilla, Sevilla, Spain; Hepatic and Digestive Diseases Networking Biomedical Research Centre (CIBERehd), Madrid, Spain; Digestive Diseases Unit, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
- 3 Servicio de Aparato Digestivo, Hospital Clínico Universitario de Valencia, INCLIVA Instituto de Investigación Sanitaria, Valencia, Spain.
- 4 Hepatic and Digestive Diseases Networking Biomedical Research Centre (CIBERehd), Madrid, Spain; Sección de Hepatología, Servicio de Aparato Digestivo, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
- 5 SeLiver Group, Instituto de Biomedicina de Sevilla/CSIC/Universidad de Sevilla, Sevilla, Spain; Hepatic and Digestive Diseases Networking Biomedical Research Centre (CIBERehd), Madrid, Spain. Electronic address: [email protected].
No abstract available